Richard Nolan Townsend, Chief Executive Officer at Lexeo Therapeutics, Inc. (LXEO), sold 4,326 shares at $4.41 ($19K) on 2025-02-19, disclosed to the SEC on 2025-02-21.
Open-market sale of $19k LXEO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LXEO | SELL | 2026-05-20 | $17K | — | Filing → |
| LXEO | SELL | 2026-04-07 | $313K | — | Filing → |
| LXEO | SELL | 2026-02-20 | $65K | — | Filing → |